Deze website maakt gebruik van cookies. Op deze manier kunnen we u een meer gepersonaliseerde dienstverlening bieden. Door het gebruik van deze website gaat u akkoord met het feit dat wij 'cookies' gebruiken. Lees onze privacy policy voor meer informatie over het gebruik van cookies en hoe u deze kunt deleten en blokkeren.
  • BDO assisted BVI Medical with the financial and tax due diligence on Arcadophta
Case study:

BDO assisted BVI Medical with the financial and tax due diligence on Arcadophta

24 december 2019

BVI, one of the fastest growing diversified companies in ophthalmology has acquired Arcadophtha SARL (Arcad), a France-based ophthalmic company specializing in silicon oils, gases and perfluorocarbons used in vitreoretinal surgery. Growth of the Arcad products will be accelerated through BVI's broad-reaching commercial infrastructure established with the Vitreq line of vitreoretinal surgical products.

Arcad has developed a proprietary process of purification and fractionation that delivers high quality products for use by surgeons. Additionally, the company has developed certain single-use and easy to administer delivery systems for products.  Arcad brings over 25 years of expertise in the ophthalmic space and a strong history in close collaboration with surgeons worldwide.
 
BDO Transaction Services team, led by Alexander Veithen (BDO Belgium) and Sacha Boksenbaum (BDO France), assisted BVI in this transaction by conducting the financial and tax buy-side due diligence work.